Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,297 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.
Fisher RI, Rosenberg SA, Fyfe G. Fisher RI, et al. Among authors: rosenberg sa. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S55-7. Cancer J Sci Am. 2000. PMID: 10685660 Clinical Trial.
Clinical application of IL6 in cancer therapy.
Mulé JJ, Marcus SG, Yang JC, Weber JS, Rosenberg SA. Mulé JJ, et al. Among authors: rosenberg sa. Res Immunol. 1992 Sep;143(7):777-9. doi: 10.1016/0923-2494(92)80023-e. Res Immunol. 1992. PMID: 1439156 Clinical Trial. No abstract available.
A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.
Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA. Lange JR, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Nov;12(4):265-71. doi: 10.1097/00002371-199211000-00007. J Immunother (1991). 1992. PMID: 1477077 Clinical Trial.
Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy.
Sherry RM, Pass HI, Rosenberg SA, Yang JC. Sherry RM, et al. Among authors: rosenberg sa. Cancer. 1992 Apr 1;69(7):1850-5. doi: 10.1002/1097-0142(19920401)69:7<1850::aid-cncr2820690729>3.0.co;2-i. Cancer. 1992. PMID: 1551067 Clinical Trial.
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.
Weber JS, Yang JC, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. Weber JS, et al. Among authors: rosenberg sa. J Clin Oncol. 1992 Jan;10(1):33-40. doi: 10.1200/JCO.1992.10.1.33. J Clin Oncol. 1992. PMID: 1727923
Lack of antihypertensive effect of interleukin-2 administration in humans.
Pockaj BA, Rosenberg SA. Pockaj BA, et al. Among authors: rosenberg sa. J Immunother (1991). 1991 Dec;10(6):456-9. doi: 10.1097/00002371-199112000-00010. J Immunother (1991). 1991. PMID: 1768680
Murine studies using polyethylene glycol-modified recombinant human interleukin 2 (PEG-IL-2): antitumor effects of PEG-IL2 alone and in combination with adoptive cellular transfer.
Yang JC, Schwarz SL, Perry-Lalley DM, Rosenberg SA. Yang JC, et al. Among authors: rosenberg sa. Lymphokine Cytokine Res. 1991 Dec;10(6):475-80. Lymphokine Cytokine Res. 1991. PMID: 1804310
Immunotherapy and gene therapy of cancer.
Rosenberg SA. Rosenberg SA. Cancer Res. 1991 Sep 15;51(18 Suppl):5074s-5079s. Cancer Res. 1991. PMID: 1884383 Review.
Thyroid dysfunction associated with immunotherapy for patients with cancer.
Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA. Schwartzentruber DJ, et al. Among authors: rosenberg sa. Cancer. 1991 Dec 1;68(11):2384-90. doi: 10.1002/1097-0142(19911201)68:11<2384::aid-cncr2820681109>3.0.co;2-a. Cancer. 1991. PMID: 1933775
Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluid.
Belldegrun A, Kasid A, Uppenkamp M, Rosenberg SA. Belldegrun A, et al. Among authors: rosenberg sa. Cancer Immunol Immunother. 1990;31(1):1-10. doi: 10.1007/BF01742489. Cancer Immunol Immunother. 1990. PMID: 1968360
1,297 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback